These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1724862)

  • 1. [The role of the surface antigens of Pseudomonas pseudomallei in the pathogenesis of melioidosis].
    Piven' NN; Smirnova VI; Kapliev VI; Podzolkova GG; Khrapova NP
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Oct; (10):8-12. PubMed ID: 1724862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The immunogenicity and heterogeneity of Pseudomonas pseudomallei surface antigen 8].
    Piven' NN; Smirnova VI; Viktorov DV; Kovalenko AA; Farber SM; Iarulin RG; Podzolkova GG
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (4):75-8. PubMed ID: 9027183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pseudomonas pseudomallei and Pseudomonas mallei--capsule-forming bacteria].
    Popov SF; Kurilov VIa; Iakovlev AT
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (5):32-6. PubMed ID: 8525729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Burkholderia mallei and Burkholderia pseudomallei. Study of immuno- and pathogenesis of glanders and melioidosis. Heterologous vaccines].
    Manzeniuk IN; Galina EA; Dorokhin VV; Kalachev IIa; Borzenkov VN; Svetoch EA
    Antibiot Khimioter; 1999; 44(6):21-6. PubMed ID: 10422574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathogenicity of Burkholderia pseudomallei: extracellular and surface antigen functions].
    Piven' NN; Iliukhin VI
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (6):94-9. PubMed ID: 11210655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of and immunity to melioidosis.
    Brett PJ; Woods DE
    Acta Trop; 2000 Feb; 74(2-3):201-10. PubMed ID: 10674650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide from nonvirulent Ara+ Burkholderia pseudomallei isolates is immunologically indistinguishable from lipopolysaccharide from virulent Ara- clinical isolates.
    Anuntagool N; Intachote P; Wuthiekanun V; White NJ; Sirisinha S
    Clin Diagn Lab Immunol; 1998 Mar; 5(2):225-9. PubMed ID: 9521147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoblot analysis to demonstrate antigenic variability of clinical isolated. Pseudomonas pseudomallei.
    Lertmemongkolchai G; Manmontri W; Leelayuwat C; Romphruk A; Waropastrakul S
    Asian Pac J Allergy Immunol; 1991 Jun; 9(1):5-8. PubMed ID: 1723272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type III secretion system cluster 3 is required for maximal virulence of Burkholderia pseudomallei in a hamster infection model.
    Warawa J; Woods DE
    FEMS Microbiol Lett; 2005 Jan; 242(1):101-8. PubMed ID: 15621426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virulence of the Melioidosis Pathogen Burkholderia pseudomallei Requires the Oxidoreductase Membrane Protein DsbB.
    McMahon RM; Ireland PM; Sarovich DS; Petit G; Jenkins CH; Sarkar-Tyson M; Currie BJ; Martin JL
    Infect Immun; 2018 May; 86(5):. PubMed ID: 29440370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunogenic potential of glanders and melioidosis agents].
    Kalachev II; Baídus' AN; Ivanova OA; Ganina EA; Boldyrev IA; Svetoch EA
    Vestn Ross Akad Med Nauk; 1997; (6):32-7. PubMed ID: 9289277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immune response in experimental animals immunized with Burkholderia pseudomallei surface antigens].
    Avrorova IV; Piven' NN; Zhukova SI; Viktorov DV; Khrapova NP; Popov SF
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (5):85-9. PubMed ID: 15554321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ecological and biological maintenance of sapronoses exemplified by melioidosis].
    Larionov GM
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Mar; (3):36-40. PubMed ID: 3389005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nature of Pseudomonas pseudomallei antigens common to some species of microorganisms].
    Gontar' IP; Farber SM; Efremenko VI; Zakrevskiĭ VI; Denisov II
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Mar; (3):55-7. PubMed ID: 6203267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunotropic and immunogenic properties of Burkholderia pseudomallei surface and membrane antigens].
    Piven' NN; Rybkin VS; Plekhanova NG; Zhukova SI; Viktorov DV; Avrorova IV; Demediuk EA; Drefs NM; Popov SF
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (1):29-33. PubMed ID: 11236497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence.
    DeShazer D; Brett PJ; Woods DE
    Mol Microbiol; 1998 Dec; 30(5):1081-100. PubMed ID: 9988483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Burkholderia pseudomallei Strains Using a Murine Intraperitoneal Infection Model and In Vitro Macrophage Assays.
    Welkos SL; Klimko CP; Kern SJ; Bearss JJ; Bozue JA; Bernhards RC; Trevino SR; Waag DM; Amemiya K; Worsham PL; Cote CK
    PLoS One; 2015; 10(4):e0124667. PubMed ID: 25909629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global map of growth-regulated gene expression in Burkholderia pseudomallei, the causative agent of melioidosis.
    Rodrigues F; Sarkar-Tyson M; Harding SV; Sim SH; Chua HH; Lin CH; Han X; Karuturi RK; Sung K; Yu K; Chen W; Atkins TP; Titball RW; Tan P
    J Bacteriol; 2006 Dec; 188(23):8178-88. PubMed ID: 16997946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against
    Zimmerman SM; Dyke JS; Jelesijevic TP; Michel F; Lafontaine ER; Hogan RJ
    Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28507073
    [No Abstract]   [Full Text] [Related]  

  • 20. Exopolysaccharides of Burkholderia pseudomallei.
    Steinmetz I; Nimtz M; Wray V; Häussler S; Reganzerowski A; Brenneke B
    Acta Trop; 2000 Feb; 74(2-3):211-4. PubMed ID: 10674651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.